Researchers have identified key access barriers to antibiotics in low-, middle-, and high-income countries. The report makes several recommendations proposing action on R&D, strengthening regulatory capacities, encouraging the development and diversification of quality local manufacturing, exploring innovative funding to reduce out-of-pocket payments, better treatment guidelines, and awareness raising.